Israel to initiate human trials of potential Covid-19 vaccine
The Israel Institute for Biological Research (IIBR) has obtained regulatory approval to initiate human clinical...
Prilenia Therapeutics to fund late-stage clinical trials in HD and ALS
Clinical stage biotechnology firm Prilenia Therapeutics has raised $62.5m through a Series A financing round...
MGC begins Phase II study of ArtemiC to treat Covid-19
MGC Pharmaceuticals has started a Phase II clinical trial of ArtemiC for the treatment of...
MGC receives second approval for Covid-19 trial in Israel
MGC Pharmaceuticals has received a second human research ethics committee approval in Israel to conduct...
Initial data shows improvement in Covid-19 with RedHill’s opaganib
RedHill Biopharma has reported preliminary data from a compassionate use programme of opaganib (Yeliva, ABC294640)...
Pluristem begins dosing with Covid-19 therapy in Israel
Pluristem Therapeutics has started dosing Covid-19 patients in Israel with PLX cells under a compassionate...
VBL Therapeutics initiates VB-111’s trial in colorectal cancer
VBL Therapeutics has initiated a Phase II clinical trial of a VB-111 and Opdivo (nivolumab)...
Teva’s deutetrabenazine fails in paediatric Tourette syndrome trials
Results from Teva Pharmaceutical Industries have revealed that deutetrabenazine did not meet the primary endpoint...
VBL Therapeutics publishes Phase II and III data of VB-111
VBL Therapeutics, a clinical biopharmaceutical firm engaged in developing cancer treatments, has published clinical data...